Supported by the FOXG1 Research Foundation and University at Buffalo (UB)
FOXG1 Research Center
More than a thousand individuals have been diagnosed with FOXG1 syndrome over the world. This number is likely to increase substantially as diagnostic measures improve in more countries. FOXG1 Research Center provides resources to the FS parents and FOXG1 researchers.
Our Research
FOXG1 Research Center (FRC) is UB’s new research center devoted to the studies of FOXG1 syndrome. FRC aims to translate new discoveries from the lab to clinical trials and develop a cure for FOXG1 syndrome, as well as related autism spectrum disorders. The ultimate goal is to help children in the world impacted by this disorder.
Our research has found that the FOXG1 gene and protein remain active in mice after birth, providing hope that some symptoms can be alleviated.
Planned research topics for the FRC include drug discovery, sensory issues like sleep disturbance and mood changes, and the role of mitochondria in neurodevelopmental disorders.
Collaborators at UB working with FRC and Lee Labs include:
-
Denise Ferkey, Associate Professor and Associate Chair, Department of Biological Sciences.
-
Michael Yu, Associate Professor, Department of Biological Sciences.
-
Wei Sun, Associate Professor and Director of Undergraduate Studies, Department of Communicative Disorders and Sciences.
-
Priya Banerjee, Associate Professor, Department of Physics.
-
Yungki Park, Associate Professor, Department of Biochemistry.
-
Edward Kwon, Assistant Professor, Department of Oral Biology.
​
Latest News
